Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats

Archives of Pharmacal Research

Volumn 32, Issue 12, 2009, Pages 1721-1725

  Choi, Jun Shik ^a   Burm, Jin Pil ^b  

^a Chosun University   (South Korea)

^b Chosun Nursing College   (South Korea)

Author keywords

CYP3A subfamily; Epigallocatechin gallate (EGCG); Nicardipine; P glycoprotein; Pharmacokinetics; Rats

Indexed keywords

CYTOCHROME P450 3A; EPIGALLOCATECHIN GALLATE; GLYCOPROTEIN P; NICARDIPINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG INHIBITION; INTESTINE; LIVER LEVEL; MALE; NONHUMAN; PROTEIN FAMILY; RAT;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; CALCIUM CHANNEL BLOCKERS; CATECHIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP3A; DRUG INTERACTIONS; FREE RADICAL SCAVENGERS; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; NICARDIPINE; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77249129711     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-2209-7     Document Type: Article

References (21)

1. W. L. Chiou 1978 Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve J. Pharmacokinet. Biopharm. 6 539 549 10.1007/BF01062108 1:CAS:528:DyaE1MXpslanuw%3D%3D 731416
2. Chu, D. C. and Juneja, L. R., Chemistry and Applications of Green Tea, in: Yamamoto, T., Juneja, L. R., Chu, D. C., Kim, M. (Eds.). CRC Press, New York, pp. 13-22, (1997).
3. R. A. Dixon C. L. Steele 1999 Flavonoids and isoflavonoidsa gold mine for metabolic engineering Trends Plant Sci. 4 394 400 10.1016/S1360-1385(99)01471-5 10498963 (Pubitemid 29471622)
4. R. J. Eastwood C. Galustian R. K. Bhamra D. W. Holt 1990 High-performance liquid chromatographic method for the measurement of nicardipine in plasma or serum J. Chromatogr. 530 463 468 10.1016/S0378-4347(00)82351-8 1:CAS:528:DyaK3cXmtVCgtrw%3D 2079521 (Pubitemid 20276136)
5. Gibaldi, M. and Perrier, D., Pharmacokinetics (2nd edn). Marcel-Dekker, New York (1982).
6. D. J. Graham R. J. Dow D. Freedman E. Mroszczak T. Ling 1984 Pharmacokinetics of nicardipine following oral and intravenous administration in man Postgrad. Med. J. 4 7 10
7. D. J. Graham R. J. Dow D. J. Hall O. F. Alexander E. J. Mroszczak D. Freedman 1985 The metabolism and pharmacokinetics of nicardipine hydrochloride in man Br. J. Clin. Pharmacol. 1 23 28
8. F. P. Guengerich M. V. Martin P. H. Beaune P. Kre-mers T. Wolff D. J. Waxman 1986 Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism J. Biol. Chem. 261 5051 5060 1:CAS:528: DyaL28XktVeqtbc%3D 3514607
9. G. R. Hasegawa 1988 Nicardipine, nitrendipine, and bepridil: new calcium antagonists for cardiovascular disorders Clin. Pharm. 7 97 108 1:CAS:528:DyaL1cXht1eqsb4%3D 3280222
10. J. V. Higdon B. Frei 2003 Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions Crit. Rev. Food Sci. Nutr. 43 89 143 10.1080/10408690390826464 1:CAS:528:DC%2BD3sXjsl2ltrw%3D 12587987 (Pubitemid 38552312)
11. J. Hong J. D. Lambert S. H. Lee P. J. Sinko C. S. Yang 2003 Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites Biochem. Biophys. Res. Commun. 310 222 227 10.1016/j.bbrc.2003.09.007 1:CAS:528:DC%2BD3sXnsVWktrY%3D 14511674 (Pubitemid 37162786)
12. Y. P. Hu C. Chapey J. Robert 1996 Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation Cancer Lett. 109 203 209 10.1016/S0304-3835(96)04454-0 1:CAS:528:DyaK2sXktlekug%3D%3D 9020922 (Pubitemid 27033328)
13. E. S. Hysing J. E. Chelly M. F. Doursout C. Hartley R. G. Merin 1986 Cardiovascular effects of and interaction between calcium blocking drugs and anesthetics in chronically instrumented dogs. III. Nicardipine and isoflurane Anaesthesiology 65 385 391 10.1097/00000542-198610000-00007 1:CAS:528: DyaL28XmtFygsLc%3D
14. J. Jodoin M. Demeule R. Beliveau 2002 Inhibition of the mutldrug resistance P-glycoprotein activity by green tea polyphenols Biochim. Biophys. Acta 1542 149 159 10.1016/S0167-4889(01)00175-6 1:CAS:528:DC%2BD38Xhtlersbg%3D 11853888
15. Y. Kishi F. Okumura H. Furuya 1984 Haemodynamic effects of nicardipine hydrochloride. Studies during its use to control acute hypertension in anaesthetized patients Br. J. Anaesth. 56 1003 1007 10.1093/bja/56.9.1003 1:STN:280:DyaL2c3otVKgtg%3D%3D 6466525
16. S. Kitagawa T. Nabekura S. Kamiyama 2004 Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells J. Pharm. Pharmacol. 56 1001 1005 10.1211/0022357044003 1:CAS:528:DC%2BD2cXntFeisbo%3D 15285844 (Pubitemid 39140055)
17. Y. Kuroda Y. Hara 1999 Antimutagenic and anticarcinogenic activity of tea polyphenols Mutat. Res. 436 69 97 10.1016/S1383-5742(98)00019-2 1:CAS:528:DyaK1cXotFWhurc%3D 9878691 (Pubitemid 29044047)
18. S. Muto K. Fujita Y. Yamazaki T. Kamataki 2001 Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450 Mutat. Res. 479 197 206 1:CAS:528:DC%2BD3MXltlOjsLo%3D 11470492
19. R. J. Nijveldt E. van Nood D. E. van Hoorn P. G. Boelens K. Van Norren P. A. Van Leeuwen 2001 Flavonoids: a review of probable mechanisms of action and potential applications Am. J. Clin. Nutr. 74 418 425 1:CAS:528: DC%2BD3MXnt1Cksro%3D 11566638
20. F. Qian D. Wei Q. Zhang S. Yang 2005 Modulation of Pglycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells Biomed. Pharmacother. 59 64 69 10.1016/j.biopha.2005.01.002 1:CAS:528:DC%2BD2MXivVSnsLg%3D 15795098 (Pubitemid 40417515)
21. E. J. Wang C. N. Casciano R. P. Clement W. W. Johnson 2000 Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence Biochim. Biophys. Acta 1481 63 74 1:CAS:528:DC%2BD3cXmtVCqsbw%3D 10962093